<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Research Strategy (Approach, Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I Approach: evidence-weighted hypothesis prioritization workflow, Bayesian updating, validation plan, milestones, KPIs, and risks & mitigation."/>

  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }

    .section{
      max-width: 1120px;
      margin: 0 auto;
      padding: 28px 20px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.35rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 6px;
    }

    h2{
      font-size: 1.15rem;
      font-weight: 760;
      color:#f9fafb;
      margin: 14px 0 8px;
    }

    p{
      margin: 0 0 10px;
      font-size: .95rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns: minmax(0,1.1fr) minmax(0,1fr);
      gap:18px;
      margin-top: 10px;
      align-items:start;
    }

    .card{
      border-radius: 16px;
      padding: 14px 16px;
      background: rgba(15,23,42,0.84);
      border: 1px solid rgba(148,163,184,0.28);
      box-shadow: 0 18px 45px rgba(15,23,42,0.55);
    }

    .card h3{
      margin: 0 0 8px;
      font-size: .95rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
    }

    ul{
      margin: 6px 0 0;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .94rem;
    }
    li{ margin-bottom: 6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.74rem;
      padding: 5px 9px;
      border-radius: 999px;
      border: 1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
    }

    .callout{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size: .92rem;
      color:#e5e7eb;
      margin-top: 12px;
    }
    .callout strong{ color:#22c55e; }

    .math{
      margin-top:10px;
      padding: 12px 14px;
      border-radius: 14px;
      border: 1px solid rgba(148,163,184,0.28);
      background: rgba(2,6,23,0.35);
      overflow:auto;
    }
    .math pre{
      margin:0;
      white-space:pre;
      font-family: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", monospace;
      font-size: 13.4px;
      color:#e5e7eb;
      line-height:1.45;
    }
    .math .note{
      margin-top:8px;
      color:#cbd5e1;
      font-size:.86rem;
    }

    /* Table */
    .table{
      width:100%;
      border-collapse: collapse;
      margin-top: 10px;
      overflow:hidden;
      border-radius: 14px;
      border: 1px solid rgba(148,163,184,0.28);
      background: rgba(15,23,42,0.6);
    }
    .table th, .table td{
      padding: 12px 12px;
      border-bottom: 1px solid rgba(148,163,184,0.18);
      vertical-align: top;
      font-size: .95rem;
      color:#e5e7eb;
    }
    .table th{
      font-size: .82rem;
      text-transform: uppercase;
      letter-spacing: .14em;
      color:#a5b4fc;
      background: rgba(2,6,23,0.35);
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width: 920px){
      .grid-2{ grid-template-columns: minmax(0,1fr); }
    }

    /* Figure styles */
    .pgx-figure{ margin: 0; }
    .pgx-figure figcaption{
      margin: 10px 0 10px;
      font-size: 13.5px;
      color: #e5e7eb;
    }
    .pgx-figure-panel{
      background: #f1f5f9;
      border-radius: 14px;
      padding: 14px 14px;
      border: 1px solid rgba(15,23,42,0.25);
      box-shadow: 0 10px 28px rgba(0,0,0,0.35);
      overflow:hidden;
    }
    .pgx-figure-panel svg{
      display:block;
      width:100%;
      height:auto;
    }
    .pgx-figure-panel svg .box{
      fill:#f8fafc;
      stroke:#0f172a;
      stroke-width:2;
    }
    .pgx-figure-panel svg .box-soft{
      fill:#e2e8f0;
      stroke:#0f172a;
      stroke-width:2;
    }
    .pgx-figure-panel svg .arrow{
      stroke:#0f172a;
      stroke-width:2.2;
    }
    .pgx-figure-panel svg marker path{ fill:#0f172a; }
    .pgx-figure-panel svg text{ fill:#0b1220; }

    /* Print */
    @media print {
      header, footer { display: none !important; }
      body { background:#fff !important; color:#111 !important; }
      p, li { color:#111 !important; }
      h1, h2, h3 { color:#111 !important; }
      * { box-shadow: none !important; }
      @page { size: Letter; margin: 0.5in; }
      .section { max-width: 100% !important; padding: 0 !important; }
      .pgx-figure figcaption { color:#111 !important; }
      .pgx-figure-panel{
        background:#fff !important;
        border: 1px solid #111 !important;
      }
      .math pre{ color:#111 !important; }
      .math{ border:1px solid #111 !important; background:#fff !important; }
      .callout{ border:1px dashed #111 !important; background:#fff !important; color:#111 !important; }
      .callout strong{ color:#111 !important; }
      .pill{ border:1px solid #111 !important; color:#111 !important; background:#fff !important; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html" class="active">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Research Strategy – Approach (Phase I Workflow & Validation)</h1>
        <div class="meta">
          PromptGenix LLC &middot; Contact: dohoon.kim1@icloud.com &middot; promptgenix.org
        </div>
      </div>

      <div class="kicker">Phase I goal</div>
      <h2>Build a validated prototype that prioritizes testable biological hypotheses using evidence-weighted inference over public data and literature.</h2>
      <p>
        Phase I focuses on engineering robustness, reproducibility, and measurable scientific utility for a
        <strong>hypothesis intelligence engine</strong>.
        Validation will rely exclusively on public sources (e.g., GEO/SRA, FlowRepository, and PubMed/PMC),
        minimizing IP or data-use conflicts while enabling transparent evaluation.
      </p>
      <p>
        In this project, analysis pipelines are treated as <strong>evidence generators</strong>—not the end product.
        The primary Phase I deliverable is a system that produces <strong>ranked hypotheses with probabilistic confidence</strong>,
        explicit evidence links, and clear uncertainty labeling. (LLMs are used for interpretability only—never to set confidence.)
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>Workflow overview</h3>
          <ul>
            <li><strong>Inputs:</strong> Disease-, protein-, pathway-, or cell-type–centric questions (optionally with accession IDs).</li>
            <li><strong>Evidence pool:</strong> automated retrieval of relevant public datasets + metadata + literature signals.</li>
            <li><strong>Evidence generation:</strong> standardized feature extraction (effect sizes, uncertainty, reproducibility, context descriptors).</li>
            <li><strong>Decision engine:</strong> statistical scoring + Bayesian updating to compute confidence distributions for candidate hypotheses.</li>
            <li><strong>Interpretability layer:</strong> evidence-constrained LLM explanations (no evidence → no claim).</li>
            <li><strong>Outputs:</strong> ranked hypotheses + confidence bands + “why” rationale + recommended follow-up experiments.</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Evidence objects</span>
            <span class="pill">Bayesian updating</span>
            <span class="pill">Uncertainty labels</span>
            <span class="pill">Traceable outputs</span>
          </div>
        </div>

        <div class="card">
          <h3>Hypothesis Prioritization Engine (traceable)</h3>
          <p>
            PromptGenix prioritizes <strong>testable hypotheses</strong> by combining quantitative evidence with structured biological priors.
            Large language models are used <strong>only</strong> to contextualize and explain rankings—not to determine them.
          </p>
          <ul>
            <li><strong>Candidate hypothesis set:</strong> structured templates (e.g., “Gene X ↑ in Disease Y within Cell Type Z”).</li>
            <li><strong>Evidence strength:</strong> effect size + uncertainty + directionality + cross-dataset consistency.</li>
            <li><strong>Bayesian confidence:</strong> priors (pathways, cell specificity, literature support) updated by observed evidence.</li>
            <li><strong>Ranking outputs:</strong> posterior mean + credible interval + evidence coverage (supporting vs. conflicting).</li>
            <li><strong>Actionability:</strong> suggested next-step experiments/analyses and required data per hypothesis.</li>
          </ul>
          <div class="callout">
            <strong>Phase I emphasis:</strong> transparent ranking with uncertainty—avoiding black-box “confidence.”
          </div>
        </div>
      </div>

      <!-- FULL-WIDTH FIGURE -->
      <div class="card" style="margin-top:18px;">
        <h3>Bayesian Evidence-to-Confidence Workflow (Figure X)</h3>

        <figure class="pgx-figure">
          <figcaption><strong>Figure X.</strong> Stepwise workflow of the PromptGenix decision engine: query intake → retrieval/harmonization → hypothesis templates → evidence extraction → Bayesian updating → posterior confidence → evidence-constrained interpretation.</figcaption>

          <div class="pgx-figure-panel">
            <svg viewBox="0 0 1420 420" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Bayesian Evidence-to-Confidence Flow (Two-row tidy)">
              <defs>
                <marker id="arrow" markerWidth="12" markerHeight="12" refX="10" refY="6" orient="auto">
                  <path d="M0,0 L12,6 L0,12 Z"></path>
                </marker>
              </defs>

              <!-- TOP ROW -->
              <g font-family="Arial, sans-serif" font-size="18">
                <rect class="box" x="70" y="50" width="240" height="92" rx="12"></rect>
                <text x="190" y="82" text-anchor="middle" font-weight="800">User Query</text>
                <text x="190" y="108" text-anchor="middle" font-size="15">(disease / protein</text>
                <text x="190" y="128" text-anchor="middle" font-size="15">/ cell-type)</text>

                <line class="arrow" x1="310" y1="96" x2="360" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="360" y="50" width="260" height="92" rx="12"></rect>
                <text x="490" y="82" text-anchor="middle" font-weight="800">(1) Retrieval</text>
                <text x="490" y="108" text-anchor="middle" font-size="15">Public datasets + literature</text>

                <line class="arrow" x1="620" y1="96" x2="670" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="670" y="50" width="290" height="92" rx="12"></rect>
                <text x="815" y="82" text-anchor="middle" font-weight="800">(2) Harmonization</text>
                <text x="815" y="108" text-anchor="middle" font-size="15">Metadata normalization</text>
                <text x="815" y="128" text-anchor="middle" font-size="15">QC + batch/study modeling</text>

                <line class="arrow" x1="960" y1="96" x2="1010" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="1010" y="50" width="320" height="92" rx="12"></rect>
                <text x="1170" y="82" text-anchor="middle" font-weight="800">(3) Hypotheses</text>
                <text x="1170" y="108" text-anchor="middle" font-size="15">Structured templates</text>
                <text x="1170" y="128" text-anchor="middle" font-size="15">(testable statements)</text>
              </g>

              <!-- Connector: 3 -> 4 -->
              <path class="arrow" d="M1170 142 V190 H250 V225" fill="none" marker-end="url(#arrow)"></path>

              <!-- BOTTOM ROW -->
              <g font-family="Arial, sans-serif" font-size="18">
                <rect class="box" x="70" y="225" width="360" height="92" rx="12"></rect>
                <text x="250" y="257" text-anchor="middle" font-weight="800">(4) Evidence Extraction</text>
                <text x="250" y="283" text-anchor="middle" font-size="15">Effect sizes + uncertainty</text>
                <text x="250" y="303" text-anchor="middle" font-size="15">quality weights + directionality</text>

                <line class="arrow" x1="430" y1="271" x2="480" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box-soft" x="480" y="225" width="340" height="92" rx="12"></rect>
                <text x="650" y="257" text-anchor="middle" font-weight="900">(5) Bayesian Update</text>
                <text x="650" y="283" text-anchor="middle" font-size="15">Prior P(H) × Likelihood P(E|H)</text>
                <text x="650" y="303" text-anchor="middle" font-size="15">→ Posterior P(H|E)</text>

                <line class="arrow" x1="820" y1="271" x2="870" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box" x="870" y="225" width="250" height="92" rx="12"></rect>
                <text x="995" y="257" text-anchor="middle" font-weight="800">(6) Confidence</text>
                <text x="995" y="283" text-anchor="middle" font-size="15">Posterior mean/median</text>
                <text x="995" y="303" text-anchor="middle" font-size="15">+ 95% CrI + robustness</text>

                <line class="arrow" x1="1120" y1="271" x2="1160" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box" x="1150" y="225" width="260" height="92" rx="12"></rect>
                <text x="1280" y="257" text-anchor="middle" font-weight="800">(7) Interpretability</text>
                <text x="1280" y="283" text-anchor="middle" font-size="15">LLM rationale constrained</text>
                <text x="1280" y="303" text-anchor="middle" font-size="15">to evidence + next steps</text>
              </g>
            </svg>
          </div>
        </figure>
      </div>

      <div class="kicker" style="margin-top:18px;">How Bayesian confidence is computed</div>
      <h2>We operationalize priors and likelihoods from structured biological signals and standardized evidence features.</h2>

      <div class="callout">
        <strong>Key design choice:</strong> LLMs do not set confidence. Confidence is computed by an evidence-weighted Bayesian decision engine; the LLM only explains rankings using linked evidence objects and citations (supporting or conflicting), with uncertainty explicitly stated.
      </div>

      <div class="card" style="margin-top:12px;">
        <h3>Bayesian model (Phase I, reviewer-friendly)</h3>
        <p style="margin-bottom:8px;">
          For each hypothesis <strong>H</strong> (e.g., “Gene X upregulated in Disease Y in Cell Type Z”), we compute a posterior confidence <strong>P(H | E)</strong>
          given evidence <strong>E</strong> aggregated across public datasets and literature-derived signals.
        </p>

        <div class="math" aria-label="Bayesian equations">
<pre>
(1) Bayes rule:
    P(H | E) = [ P(E | H) * P(H) ] / P(E)

(2) Odds form (useful for additive scoring):
    Odds(H | E) = Odds(H) * LR(E)
    logit(P(H | E)) = logit(P(H)) + log LR(E)

    where Odds(H) = P(H)/(1-P(H)),
          LR(E)   = P(E|H) / P(E|¬H)

(3) Prior construction (bounded, interpretable):
    Let s_path, s_cell, s_lit ∈ [0,1] be normalized signals:
      s_path = pathway relevance score (KEGG/Reactome membership, enrichment)
      s_cell = cell-type specificity index (marker/co-expression specificity)
      s_lit  = literature support score (support vs conflict, recency-weighted)

    Prior log-odds:
      logit(P(H)) = b0 + b1*s_path + b2*s_cell + b3*s_lit

(4) Evidence likelihood from standardized evidence objects:
    For dataset i, evidence object includes:
      effect size:  d_i   (e.g., log2FC, Δabundance, Δfreq)
      uncertainty:  se_i  (or CI/p-value converted to precision)
      quality:      q_i   (QC, batch robustness, sample size proxy)
      consistency:  c_i   (directional agreement across datasets/contexts)

    A simple Phase I log-likelihood ratio (LLR) proxy:
      z_i = d_i / se_i
      LLR(E_i) = w_i * z_i * sign(d_i)   where w_i = clamp(q_i, 0, 1)

    Aggregate across datasets:
      log LR(E) = Σ_i LLR(E_i)  +  λ * c_global

(5) Posterior and reporting:
    P(H | E) = sigmoid( logit(P(H)) + log LR(E) )
    Report: posterior mean (or median), 95% credible interval (CrI),
            and evidence coverage: supporting vs conflicting vs missing.
</pre>
          <div class="note">
            <strong>Notes:</strong> Phase I uses bounded, auditable components (signals and evidence objects) so reviewers can see exactly
            what drives confidence. More expressive hierarchical models (e.g., random effects across studies, robust priors) are Phase II extensions.
          </div>
        </div>

        <div class="callout" style="margin-top:12px;">
          <strong>Traceability rule:</strong> Each term above is computed from (a) versioned pipeline outputs (e.g., effect size, SE, QC) or
          (b) cited public literature signals. The narrative layer can only reference these linked artifacts.
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Phase I validation plan</div>
      <h2>Public-data evaluation with measurable KPIs.</h2>

      <table class="table" aria-label="Phase I validation plan table">
        <thead>
          <tr>
            <th style="width:18%;">Work package</th>
            <th style="width:52%;">What we will do</th>
            <th style="width:30%;">Success metrics (examples)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>WP1</strong><br/>Evidence layer</td>
            <td>
              Build a robust ingest + evidence feature extraction layer for selected public datasets.
              Generate standardized evidence objects (effect sizes, uncertainty, reproducibility, context descriptors)
              suitable for deterministic re-runs and downstream inference.
            </td>
            <td>
              ≥90% reproducibility across reruns (same inputs/configs).<br/>
              Evidence objects produced for ≥80% of targeted datasets despite heterogeneity.
            </td>
          </tr>
          <tr>
            <td><strong>WP2</strong><br/>Decision engine</td>
            <td>
              Implement statistical scoring and Bayesian updating to compute posterior confidence distributions for candidate hypotheses.
              Produce ranked outputs with uncertainty annotations and explicit supporting vs. conflicting evidence summaries.
            </td>
            <td>
              Calibrated confidence outputs (posterior intervals behave as expected in held-out tests).<br/>
              Clear traceability: each ranked hypothesis links to evidence objects + citations.
            </td>
          </tr>
          <tr>
            <td><strong>WP3</strong><br/>Interpretability & reports</td>
            <td>
              Generate reviewer-ready HTML/PDF artifacts: ranked hypotheses, confidence bands, evidence coverage,
              citations, and recommended next steps. LLM narratives are constrained to evidence objects and must cite sources.
            </td>
            <td>
              End-to-end run completes within &lt;24 hours from accession-driven inputs (dataset-dependent).<br/>
              ≥80% “useful” rating by pilot users (guides at least one concrete experimental/analysis decision).
            </td>
          </tr>
        </tbody>
      </table>

      <div class="callout">
        <strong>Data-use boundary:</strong> Phase I evaluation uses public datasets only (GEO/SRA/FlowRepository) and public literature sources,
        enabling clean SBIR review and minimizing IP concerns.
      </div>

      <div class="kicker" style="margin-top:18px;">Risks &amp; Mitigation</div>
      <h2>Practical risks addressed with explicit fallback strategies.</h2>

      <div class="grid-2">
        <div class="card">
          <h3>Technical risks</h3>
          <ul>
            <li><strong>Dataset heterogeneity:</strong> inconsistent metadata, formats, and cohort contexts across repositories.</li>
            <li><strong>Evidence sparsity:</strong> some hypotheses may lack sufficient supporting data or have conflicting signals.</li>
            <li><strong>Compute variability:</strong> differences between local and cloud environments affecting deterministic reruns.</li>
            <li><strong>LLM overreach:</strong> narrative may overstate conclusions without strict constraints.</li>
          </ul>
        </div>

        <div class="card">
          <h3>Mitigation strategies</h3>
          <ul>
            <li><strong>Robust ingest:</strong> schema detection + validation + standardized evidence templates and QC gates.</li>
            <li><strong>Evidence coverage labeling:</strong> explicit “supporting vs. conflicting vs. missing” flags per hypothesis.</li>
            <li><strong>Deterministic runs:</strong> pinned versions, config snapshots, and checksums for reproducibility.</li>
            <li><strong>Traceability guardrails:</strong> LLM can only reference approved evidence objects; no evidence → no claim.</li>
            <li><strong>Fallback mode:</strong> if evidence is weak, output “candidate hypotheses” with low-confidence tags and data-needed guidance.</li>
          </ul>
        </div>
      </div>

      <div class="callout">
        <strong>Reviewer-friendly principle:</strong> Every claim must be traceable to (1) evidence objects derived from public data or (2) cited literature,
        with uncertainty explicitly stated.
      </div>

      <div class="callout">
        <strong>Phase I success criterion:</strong> Phase I does not require all prioritized hypotheses to be biologically correct,
        but demonstrable traceability, calibrated uncertainty, transparent ranking rationale, and usefulness for guiding study design decisions.
      </div>

    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
